191 related articles for article (PubMed ID: 2856880)
1. Immunological features of nonimmunogenic hyperthyroidism.
Grubeck-Loebenstein B; Derfler K; Kassal H; Knapp W; Krisch K; Liszka K; Smyth PP; Waldhäusl W
J Clin Endocrinol Metab; 1985 Jan; 60(1):150-5. PubMed ID: 2856880
[TBL] [Abstract][Full Text] [Related]
2. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
[TBL] [Abstract][Full Text] [Related]
3. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of immunological abnormalities in endemic simple goitre.
Grubeck-Loebenstein B; Kassal H; Smyth PP; Krisch K; Waldhäusl W
Acta Endocrinol (Copenh); 1986 Dec; 113(4):508-13. PubMed ID: 2878552
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune thyroid disease--a perspective.
Volpé R
Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
[TBL] [Abstract][Full Text] [Related]
6. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease.
Iwatani Y; Gerstein HC; Iitaka M; Row VV; Volpé R
J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094
[TBL] [Abstract][Full Text] [Related]
7. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
Paschke R; Vogg M; Swillens S; Usadel KH
J Clin Endocrinol Metab; 1993 Oct; 77(4):939-43. PubMed ID: 8408468
[TBL] [Abstract][Full Text] [Related]
8. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
[TBL] [Abstract][Full Text] [Related]
9. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
[TBL] [Abstract][Full Text] [Related]
10. Effect of Graves' intrathyroidal lymphocytes. Effect of Graves' disease intrathyroidal lymphocytes (ITL) on xenotransplants of human thyroid tissue in athymic nude mice.
Schumm-Draeger PM; Jungheim K; Caspar G; Hermann G; Fortmeyer HP; Wenisch HJ; Usadel KH
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():60-3. PubMed ID: 8981004
[TBL] [Abstract][Full Text] [Related]
11. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
[TBL] [Abstract][Full Text] [Related]
12. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
[TBL] [Abstract][Full Text] [Related]
13. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
14. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
Jansson R; Karlsson A; Forsum U
Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
16. Subpopulations of intrathyroidal lymphocytes in Graves' disease.
Duh YC; Su IJ; Liaw KY; Yao CC
J Formos Med Assoc; 1990 Feb; 89(2):121-5. PubMed ID: 1973719
[TBL] [Abstract][Full Text] [Related]
17. Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice.
Yoshikawa N; Arreaza G; Mukuta T; Resetkova E; Miller N; Jamieson C; Nishikawa M; Inada M; Volpé R
Clin Endocrinol (Oxf); 1994 Jul; 41(1):31-9. PubMed ID: 7519528
[TBL] [Abstract][Full Text] [Related]
18. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production.
Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474
[TBL] [Abstract][Full Text] [Related]
19. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease.
Paschke R; Vogg M; Kristoferitsch R; Aktuna D; Wawschinek O; Eber O; Usadel KH
J Clin Endocrinol Metab; 1995 Aug; 80(8):2470-4. PubMed ID: 7629244
[TBL] [Abstract][Full Text] [Related]
20. Immunological studies of autoimmune thyroid disorders: abnormalities in the inducer T cell subset and proliferative responses to autologous and allogeneic stimulation.
Fournier C; Chen H; Leger A; Charreire J
Clin Exp Immunol; 1983 Nov; 54(2):539-46. PubMed ID: 6228354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
